Photodynamic Therapy (PDT) Oncology Registry

Description

The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.

Conditions

Lung Cancer, Esophageal

Talk to us

Study Overview

On this page

Study Details

Study overview

The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.

Photodynamic Therapy (PDT) Oncology Registry

Photodynamic Therapy (PDT) Oncology Registry

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Wynnewood

Main Line Health, Lankenau Medical Center, Wynnewood, Pennsylvania, United States, 19096

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or older, male or female, diagnosed with cancer and is undergoing or has undergone Photodynamic Therapy (PDT).
  • * Patients must have undergone PDT with Photofrin® at a participating institution.
  • * Patients scheduled to undergo PDT with Photofrin®
  • * Cancer patients receiving some or all primary care (e.g.,cancer-directed surgery, systemic therapy, radiation therapy, palliative care)in the participating institution.
  • * Cancer patients with a history of any type of cancer who have been no evidence of disease(for five years but without a history of distant metastases or evidence of relapse if they meet the previous criteria).
  • * Cancer patients who present to the participating institution with a diagnosis of a simultaneous second primary.
  • * Cancer patients receiving all primary cancer care (e.g., cancer-directed surgery, chemotherapy, targeted therapy, radiation therapy, palliative care) outside of participating institution.
  • * Patients treated with photosensitizers other than Photofrin®

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Main Line Health,

Patrick Ross, MD, PhD, PRINCIPAL_INVESTIGATOR, Main Line Health

Study Record Dates

2024-12-30